Figure.
Figure. Proportion of Patients in Each Subgroup with ≥35% Reduction in Spleen Volume from Baseline at Week 48

Proportion of Patients in Each Subgroup with ≥35% Reduction in Spleen Volume from Baseline at Week 48

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal